Kelley Cunningham

Kelley Cunningham serves as a Contract Specialist within the National CMOP Office of the Department of Veterans Affairs, where she plays a pivotal role in securing the domestic production and distribution of mission-critical pharmaceuticals and medical supplies. Her responsibilities encompass the full lifecycle of procurement—from requirements definition and market research to solicitation, evaluation, and contract award—ensuring compliance with federal acquisition regulations and the agency’s mandate to maintain sovereign manufacturing capabilities. She specializes in complex, high-stakes acquisitions for sterile injectables, diagnostic agents, and essential medical consumables, prioritizing supply chain resilience and national security imperatives. Kelley maintains consistent working relationships with a select group of specialized contractors, including ALL IN SOLUTIONS LLC, ANSIBLE GOVERNMENT SOLUTIONS LLC, and INNOVATION ASSOCIATES, INC., all of which possess the technical expertise and cGMP-certified facilities required for pharmaceutical manufacturing under federal oversight. Her contracting patterns reflect a preference for established, proven vendors with demonstrated capability in aseptic processing, sterile fill-finish operations, and FDA-regulated production environments. These partnerships are built on long-term reliability, regulatory compliance, and performance history rather than frequent vendor rotation. Kelley’s procurement portfolio reflects a 100% no set-aside strategy, indicating a focus on mission-critical outcomes over socioeconomic categorization. While small business participation is not formally prioritized through set-asides, her awards are driven by technical necessity and the unique capabilities required for pharmaceutical manufacturing, which often necessitate large-scale, FDA-registered facilities beyond the capacity of most small businesses. Her primary focus is on NAICS 325412—Pharmaceutical Preparation Manufacturing—where she procures sterile injectables, radiopharmaceuticals, and other essential medications requiring stringent quality controls. Her technical expertise lies in cGMP compliance, supply chain security, and the regulatory frameworks governing controlled substance manufacturing, making her a key steward of VA’s domestic pharmaceutical sovereignty.